Pulmonary Disorders During Exercise in Patients With Obstructive Sleep Apnea
NCT ID: NCT00916773
Last Updated: 2009-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2009-04-30
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To investigate whether patients with severe obstructive sleep apnea syndrome (OSAS) are at higher risk for exercised-induced bronchoconstriction (EIB) due to baseline airway inflammation compared with age, gender, and body mass index (BMI)-matched controls.
2. To investigate the effect of 3-month continuous positive airway pressure (CPAP) therapy on EIB for patients with severe OSAS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stair Stepping Exercise Training in Patients With Obstructive Sleep Apnea Syndrome
NCT00952172
Comprehensive Respiratory Training Exercise Program in Obstructive Sleep Apnea
NCT05739617
The Effect of High Intensity Interval Exercise and Myofunctional Therapy on Obstructive Sleep Apnea
NCT05311280
The Influences of Intervention With Home-based Recovery Activity in Obstructive Sleep Apnea Syndrome
NCT02278094
The Effect of Inspiratory Muscle Training on Cognitive Functions, Cerebral Oxygenation, and Neurotrophic Factor Level in Patients With Obstructive Sleep Apnea Syndrome
NCT07329049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
continuous positive airway pressure (CPAP)
CPAP of optimal pressure used during sleep for 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Severe OSA (AHIā§30/hr)
3. BMI\<35 kg/m2
Exclusion Criteria
2. Chronic lung disease (FEV1\<70% predicted or FEV1/FVC\<70%)
3. Exercise contraindication:
* Stroke or heart attack in last 3 months
* Major cardiovascular disease
* Unstable angina
* Unable to perform cycle ergometry due to musculoskeletal problems
4. Respiratory tract infection in the past 2 weeks
5. Inability to perform acceptable-quality spirometry
6. Refuse to participate
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
School and Graduate Institute of Physical Therapy, National Taiwan University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liying Wang, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
School and Graduate Institute of Physical Therapy, National Taiwan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200712118R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.